Potential applications and human biosafety of nanomaterials used in nanomedicine
Open accessThe DOI matches its Crossref record; 228 of the 228 references it cites were found in a registry or an index.
Abstract
With the rapid development of nanotechnology, potential applications of nanomaterials in medicine have been widely researched in recent years. Nanomaterials themselves can be used as image agents or therapeutic drugs, and for drug and gene delivery, biological devices, nanoelectronic biosensors or molecular nanotechnology. As the composition, morphology, chemical properties, implant sites as well as potential applications become more and more complex, human biosafety of nanomaterials for clinical use has become a major concern. If nanoparticles accumulate in the human body or interact with the body molecules or chemical components, health risks may also occur. Accordingly, the unique chemical and physical properties, potential applications in medical fields, as well as human biosafety in clinical trials are reviewed in this study. Finally, this article tries to give some suggestions for future work in nanomedicine research. Copyright © 2017 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
A Magnetic Nanoprobe Technology for Detecting Molecular Interactions in Live Cells
Won, J., Kim, M., Yi, Y.-W., Kim, Y. H., Jung, N., & Kim, T. K. (2005) · Science · doi:10.1126/science.1112869 · Cited by 149 · cited 1×
“Won et al. (2005) reported a technology named magnetism-based interaction capture, which can be used to identify molecular targets based on induced movement of superparamagnetic NPs inside living cells.”
RetractedLiu, W., Su, P., Gonzales, A. A., Wang, N., Zhang, Z., Li, H., Webster, T. J., Wang, J., & Chen, S. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s74418 · Cited by 51 · cited 2×
“Liu et al. (2015b) developed an NIR fluorescence nanoprobe by coating CuInS2/ZnS quantum dots with an amphiphilic bioconjugate and investigated the feasibility of the constructed NIR fluorescence probe in vivo imaging.”
RetractedSilver nanoparticles as a new generation of antimicrobials
Rai, M., Yadav, A., & Gade, A. (2009) · Biotechnology Advances · doi:10.1016/j.biotechadv.2008.09.002 · Cited by 6,173 · cited 1×
“Antibacterial efficiency of nanosize Ag particles are usually associated with the total surface area of the NPs, and are much higher than traditional fine Ag particles (Rai et al., 2009).”
Cancer nanotechnology: opportunities and challenges
Ferrari, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1566 · Cited by 4,558 · cited 1×
“Nanowires and nanocantilever arrays are used for the early detection of precancerous and malignant lesions from biological fluids (Ferrari, 2005).”
Nanomaterials and nanoparticles: Sources and toxicity
Buzea, C., Pacheco, I. I., & Robbie, K. (2007) · Biointerphases · doi:10.1116/1.2815690 · Cited by 3,789 · cited 1×
“It leads to NPs being more chemically reactive meaning that a given mass of material in nanoparticulate form will be much more reactive than the same mass of material made up of larger particles (Buzea et al., 2007).”
The dawning era of polymer therapeutics
Duncan, R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1088 · Cited by 3,269
Nanoparticles in Medicine: Therapeutic Applications and Developments
Zhang, L., Gu, F., Chan, J., Wang, A., Langer, R., & Farokhzad, O. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100400 · Cited by 2,657
In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags
Qian, X., Peng, X.-H., Ansari, D. O., Yin-Goen, Q., Chen, G. Z., Shin, D. M., Yang, L., Young, A. N., Wang, M. D., & Nie, S. (2008) · Nature Biotechnology · doi:10.1038/nbt1377 · Cited by 2,201 · cited 1×
“Qian et al. (2008) reported that biocompatible and non-toxic NPs such as pegylated gold NPs and surface-enhanced Raman scattering are effective for in vivo tumor targeting and detection.”
Polymer conjugates as anticancer nanomedicines
Duncan, R. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1958 · Cited by 1,962
The emerging nanomedicine landscape
Wagner, V., Dullaart, A., Bock, A.-K., & Zweck, A. (2006) · Nature Biotechnology · doi:10.1038/nbt1006-1211 · Cited by 1,630 · cited 2×
“After extensive reviewing on clinical trial articles of nanomedicine in public journals, we found that most of them focused mainly on reporting the findings of the therapeutic effectiveness of the drugs (Wagner et al., 2006), but not on evaluating the human biosafety of the nanomaterials.”
Cited by
Drug Combinations in Breast Cancer Therapy
Fisusi, F. A., & Akala, E. O. (2019) · Pharmaceutical Nanotechnology · doi:10.2174/2211738507666190122111224 · Cited by 449
Nanocrystals: a perspective on translational research and clinical studies
Jarvis, M., Krishnan, V., & Mitragotri, S. (2019) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10122 · Cited by 162
Recent Advances in Macrophage-Mediated Drug Delivery Systems
Liang, T., Zhang, R., Liu, X., Ding, Q., Wu, S., Li, C., Lin, Y., Ye, Y., Zhong, Z., & Zhou, M. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s298159 · Cited by 126
“However, existing polymer materials are not completely inert, which prevents their clinical application as drug carriers.(36) Therefore, macrophages have been used to replace polymer materials due to their potentially higher biocompatibility and ability to be fully metabolized into safe, non-toxic products.”
Background
Metadata
- Authors
- Su, H., Wang, Y., Gu, Y., Bowman, L., Zhao, J., & Ding, M.
- Venue
- Journal of Applied Toxicology
- Publisher
- Wiley
- Published
- 2017-06-06
- Volume
- 38
- Issue
- 1
- Pages
- 3-24
- ISSN
- 0260-437X (ISSN-L)
- 1099-1263
- OpenAlex
- W2621527800
- Cited by
- 178
- References
- 228
- FWCI
- 4.40
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.